Omnicell
OMCL
299 hedge funds and large institutions have $3.55B invested in Omnicell in 2019 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 125 increasing their positions, 94 reducing their positions, and 38 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 94
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
9% more capital invested
Capital invested by funds: $3.26B → $3.55B (+$291M)
1.33% more ownership
Funds ownership: 98.94% → 100.28% (+1.3%)
5% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 38
2% less funds holding
Funds holding: 306 → 299 (-7)
84% less call options, than puts
Call options by funds: $2.85M | Put options by funds: $17.7M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$28.1M |
| 2 |
BlackRock
New York
|
+$28M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$26.8M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$21.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.2M |
Top Sellers
OMCL Hedge Fund Activity: Q2 2019 in Review
299 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2019, worth a combined $3.55B — up 8.9% from $3.26B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of OMCL and 36 opened new positions — a net loss of 2 holders — while 94 trimmed existing stakes and 125 added.
The largest buyer was Invesco, adding an estimated $28.1M. The largest seller was Bank of New York Mellon, cutting an estimated $27.9M.
- 299 institutional investors held Omnicell (OMCL) as of Q2 2019, down from 306 in Q1 2019.
- Funds reported $3.55B of Omnicell stock for Q2 2019, up 8.9% quarter-over-quarter.
- 36 funds opened new Omnicell positions in Q2 2019 and 38 closed out, a net change of -2 holders.
- The largest Omnicell buyer in Q2 2019 was Invesco, an estimated $28.1M added.
- The largest Omnicell seller in Q2 2019 was Bank of New York Mellon, an estimated $27.9M sold.
Based on aggregated 13F filings for Q2 2019.